WEREWOLF THERAPEUTICS, INC. Long-Term Debt, Maturity, Year One
WEREWOLF THERAPEUTICS, INC. (HOWL) had Long-Term Debt, Maturity, Year One of $14.40 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-09-22
- 2026-03-31: Long-Term Debt, Maturity, Year One $14.40M.
- 2025-12-31: Long-Term Debt, Maturity, Year One $9.60M.
- 2025-09-30: Long-Term Debt, Maturity, Year One $9.60M.
- 2025-06-30: Long-Term Debt, Maturity, Year One $9.60M.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2026-03-31 | $14.40M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $9.60M S-4 · filed 2026-09-22 |
| 2025-09-30 | $9.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $9.60M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $9.60M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $20.00M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $6.67M 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |